Table 3.

Logistic regression analysis of the factors associated with END in SSI patients with diabetes.

	Crude OR (95% CI)	P-value	Adjusted OR (95% CI)	P-value
Age	1.008 (0.961–1.057)	0.750	0.999 (0.937–1.065)	0.964
Initial NIHSS	1.196 (0.965–1.481)	0.102	1.073 (0.809–1.423)	0.626
NLR	1.716 (1.172–2.513)	0.006	1.768 (1.166–2.682)	0.007
BAD	2.929 (1.063–8.067)	0.038	0.577 (0.075–4.410)	0.596
Lesion diameter	1.133 (1.016–1.263)	0.025	1.223 (0.965–1.551)	0.096
FBG	1.023 (0.902–1.161)	0.722	1.024 (0.825–1.272)	0.827
2hPBG	1.046 (0.910–1.203)	0.524	1.036 (0.826–1.298)	0.761
eGFR	1.004 (0.979–1.031)	0.747	0.998 (0.966–1.032)	0.913

NIHSS, national institutes of health stroke scale; NLR, neutrophil-lymphocyte ratio; BAD, branch atheromatous disease; FBG, fasting blood glucose; 2hPBG, 2-hour postprandial blood glucose; eGFR, estimated glomerular filtration rate.